KI
MDGL icon

Kula Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Kula Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$329K Buy
+1,360
New +$371K 0.08% 434

Other funds holding MDGL

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Kula Investments's MDGL Position: Q1 2023 in Review

Kula Investments opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2023: 1,360 shares worth $329K. The stake represents 0.08% of the portfolio and ranks #434 among its holdings.

223 funds tracked by Wall St. Rank hold MDGL as of Q1 2023.

  • Kula Investments held 1,360 shares of Madrigal Pharmaceuticals worth $329K as of Q1 2023.
  • Madrigal Pharmaceuticals was a new Kula Investments position in Q1 2023.
  • Madrigal Pharmaceuticals made up 0.08% of Kula Investments's portfolio in Q1 2023, its #434 holding.
  • 223 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.